QKY-613 is a cGAS activator designed to enhance immune surveillance through nucleic acid modification pathways. As a prodrug, QKY-613 promotes the incorporation of 6mdA (N6-methyldeoxyadenosine) into viral DNA, which increases the phase separation potential and activates cGAS. In studies using virus-infected mouse models, QKY-613 demonstrated a significant reduction in mortality among aged mice. This compound is valuable for research investigating nucleic acid modification mechanisms and their role in immune response enhancement.
QKY-613 is a cGAS activator designed to enhance immune surveillance through nucleic acid modification pathways. As a prodrug, QKY-613 promotes the incorporation of 6mdA (N6-methyldeoxyadenosine) into viral DNA, which increases the phase separation potential and activates cGAS. In studies using virus-infected mouse models, QKY-613 demonstrated a significant reduction in mortality among aged mice. This compound is valuable for research investigating nucleic acid modification mechanisms and their role in immune response enhancement.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
